22
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Numerous proteins with unique characteristics are degraded by the 26S proteasome following monoubiquitination

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Significance

          A substrate-conjugated polyubiquitin chain is accepted as the “canonical” proteasomal degradation signal. Using a cellular (human and yeast) proteomic screen in the exclusive presence of nonpolymerizable ubiquitin, we show that a large group of proteins is degraded by the proteasome following monoubiquitination. The screen also unraveled polyubiquitin-dependent substrates, as they are stabilized in the presence of this ubiquitin mutant. Notably, monoubiquitination- and polyubiquitination-dependent substrates display distinct important characteristics. Monoubiquitinated proteins are of lower molecular mass and of lesser structural disorder. The two groups can be assigned to defined cellular pathways. Furthermore, some of the characteristics are confined to either human or yeast cells, suggesting that the mechanism of action/recognition of the ubiquitin system in the two organisms are different somehow.

          Abstract

          The “canonical” proteasomal degradation signal is a substrate-anchored polyubiquitin chain. However, a handful of proteins were shown to be targeted following monoubiquitination. In this study, we established—in both human and yeast cells—a systematic approach for the identification of monoubiquitination-dependent proteasomal substrates. The cellular wild-type polymerizable ubiquitin was replaced with ubiquitin that cannot form chains. Using proteomic analysis, we screened for substrates that are nevertheless degraded under these conditions compared with those that are stabilized, and therefore require polyubiquitination for their degradation. For randomly sampled representative substrates, we confirmed that their cellular stability is in agreement with our screening prediction. Importantly, the two groups display unique features: monoubiquitinated substrates are smaller than the polyubiquitinated ones, are enriched in specific pathways, and, in humans, are structurally less disordered. We suggest that monoubiquitination-dependent degradation is more widespread than assumed previously, and plays key roles in various cellular processes.

          Related collections

          Author and article information

          Journal
          Proc Natl Acad Sci U S A
          Proc. Natl. Acad. Sci. U.S.A
          pnas
          pnas
          PNAS
          Proceedings of the National Academy of Sciences of the United States of America
          National Academy of Sciences
          0027-8424
          1091-6490
          9 August 2016
          6 July 2016
          : 113
          : 32
          : E4639-E4647
          Affiliations
          [1] aTechnion Integrated Cancer Center, The Rappaport Faculty of Medicine and Research Institute, Technion–Israel Institute of Technology , Haifa, 3109602, Israel;
          [2] bSmoler Proteomic Center, Technion–Israel Institute of Technology , Haifa, 3200003, Israel;
          [3] cFaculty of Biology, Technion–Israel Institute of Technology , Haifa, 3200003, Israel;
          [4] dDepartment of Physiology, The Rappaport Faculty of Medicine and Research Institute, Technion–Israel Institute of Technology , Haifa, 3109602, Israel;
          [5] eBioinformatics and Systems Biology Program, Sanford Burnham Prebys Medical Discovery Institute , La Jolla, CA 92037;
          [6] f Max Delbrück Center for Molecular Medicine , 13125 Berlin, Germany;
          [7] gProtein Metabolism Medical Research Center, College of Medicine, Seoul National University , Seoul 110-799, South Korea;
          [8] hDepartment of Biomedical Sciences, College of Medicine, Seoul National University , Seoul 110-799, South Korea;
          [9] iVlaams Instituut voor Biotechnologie Structural Biology Research Center, Vrije Universiteit Brussel , 1050 Brussels, Belgium;
          [10] jStructural Biology Brussels, Vrije Universiteit Brussel , 1050 Brussels, Belgium;
          [11] kInstitute of Enzymology, Research Center for Natural Sciences of the Hungarian Academy of Sciences , 1117 Budapest, Hungary
          Author notes
          2To whom correspondence should be addressed. Email: aaroncie@ 123456technion.ac.il .

          Contributed by Aaron Ciechanover, June 4, 2016 (sent for review March 21, 2016; reviewed by Yinon Ben-Neriah and Ivan Dikic)

          Author contributions: O.B., I.L., T.Z., A.A., H.G., B.B., T.S., Y.T.K., M.G., P.T., and A.C. designed research; O.B., I.L., T.Z., I.K., L.H.C., H.G., and B.B. performed research; O.B., I.L., T.Z., I.K., and L.H.C. contributed new reagents/analytic tools; O.B., I.L., T.Z., A.A., A.G., S.J., L.J., T.S., Y.T.K., M.G., P.T., and A.C. analyzed data; and O.B., I.L., T.Z., T.S., Y.T.K., M.G., P.T., and A.C. wrote the paper.

          Reviewers: Y.B.-N., Hebrew University; and I.D., University of Frankfurt.

          1O.B. and I.L. contributed equally to this work.

          Article
          PMC4987823 PMC4987823 4987823 201608644
          10.1073/pnas.1608644113
          4987823
          27385826
          61f3560d-6535-42ce-8c5c-94cb674e85e2
          History
          Page count
          Pages: 9
          Funding
          Funded by: I-CORE
          Award ID: 1775/12
          Funded by: Israel Science Foundation (ISF) 501100003977
          Award ID: 572/13
          Funded by: Israel Cancer Research Fund (ICRF) 100001698
          Award ID: N/A
          Funded by: DIP
          Award ID: N/A
          Funded by: Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (AMRF) 100005984
          Award ID: N/A
          Funded by: DH | National Institute for Health Research (NIHR) 501100000272
          Award ID: GM101457
          Categories
          PNAS Plus
          Biological Sciences
          Biochemistry
          From the Cover
          PNAS Plus

          monoubiquitination,26S proteasome,protein degradation,ubiquitin replacement

          Comments

          Comment on this article

          scite_
          148
          7
          106
          0
          Smart Citations
          148
          7
          106
          0
          Citing PublicationsSupportingMentioningContrasting
          View Citations

          See how this article has been cited at scite.ai

          scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

          Similar content320

          Cited by70